Business Services Industry

Tercica to Present at Cowen & Co. 26th Annual Health Care Conference

Business Wire, March 3, 2006

BRISBANE, Calif. -- Tercica, Inc. (NASDAQ:TRCA) announced today that it will present at the upcoming Cowen & Co. 26th Annual Global Health Care Conference. Tercica's presentation will begin at 1:40 p.m. EST on Wednesday, March 8, 2006.

A live webcast of the presentation will be available via the Internet by visiting the Investors section of the company's web site at www.tercica.com. The archived presentation will be available on the web site for 90 days.

About Tercica

Tercica, Inc. is a biopharmaceutical company focused on the development and commercialization of products to improve endocrine health. The company's first product, Increlex(TM) (mecasermin (rDNA origin) injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the long-term treatment of severe Primary IGFD. For further information on Tercica, please visit www.tercica.com.

COPYRIGHT 2006 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale